Piper Sandler raises Moderna target price to $230 from $167
MRNA•Piper Sandler raised its target price for Moderna to $230 from $167.
Related News
China's yuan climbs to fresh 4-year high ahead of key policy meetings
FXI•
Automotive Ventures warns AI accelerates cybersecurity threats as defenses lag
XLK•
Viatris Inc.: Piper Sandler raises target price to $14 from $13
VTRS•
Gen Digital Inc.: Jefferies cuts target price to $27 from $30
GEN•
First Citizens BancShares: Jefferies raises target price to $2,550 from $2,300
FCNCA•